Terapia génica

 

Alyssa, a 13-year old T-cell leukemia (ALL) patient in the UK, was the first person to receive a base editing therapeutic—T cells with three base edits—and the first patient reported to benefit from base editing: complete remission, 6 months later.
1/3https://t.co/CgL6mD6U7B

— David R. Liu (@davidrliu) December 11, 2022